Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease.
Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease.
复制标题
DOI：
10.1001/jamanetworkopen.2021.48355
复制
发表时间：
2022-02-01
影响因子：
13.8
通讯作者：
Borson S
中科院分区：
文献类型：
--
作者：
Zissimopoulos J;Jacobson M;Chen Y;Borson S
这项调查研究考察了美国食品和药物管理局（FDA）批准aducanumab治疗阿尔茨海默病后，美国老年人对其潜在结果的理解和态度。
This survey study examines the understanding of aducanumab and attitudes toward its potential outcomes among older Americans after the drug's approval by the US Food and Drug Administration (FDA) for the treatment for Alzheimer disease.